Israel Life Sciences Industry ILSI www'ilsi'org'il

1
Israel Life Sciences Industry
ILSIwww.ilsi.org.il

• November 2005

2
(No Transcript)
3
Israels Life Sciences Industry 1994-2004Number
of Companies Founded
Source ILSI Data Base - 2004
4
Companies Developmental Stage466 companies
Source ILSI Data Base - 2004
5
Revenue Generating Companies
Source ILSI Data Base - 2004

• Most of the revenue generating companies are in
  the Medical Device field

6
Who are the Revenue Generators?

• Biotechnology
• Prior to 1994 Diagnostic kits
• 1994-2000 Tissue engineering and Bioinformatics
• 2000-Present Diagnostic kits
• Pharmaceutical
• Shifts from generic drugs (up 1984) to natural
  materials (from 1995)

Source ILSI Data Base - 2004
7
Main Medical Fields(367 total)
Source ILSI Data Base - 2004
8
Israels Life Science Industry Sectors466
Companies
Source ILSI Data Base - 2004
9
Israels Medical Device Companies Sub Sectors
(250 companies)
Source ILSI Data Base - 2004
10
Medical Device Sector - Applications
Source ILSI Data Base - 2004
11
Israels Biotech Companies Sub Sectors (96
companies)
Source ILSI Data Base - 2004
12
Israels Pharma Companies Sub Sectors
Source ILSI Data Base - 2004
13
Number of Graduating Israeli Students in Life
Sciences Academic Year 2001/2002
Source Israel Central Bureau of Statistics
2002/2003
14
Number of Companies in the Life Sciences
Industry Sector and Size
Source ILSI Data Base - 2004
15
Number of Employees in the Life Sciences Industry
Source ILSI Data Base - 2004
16
Medical Device Patents per million Capita
Source www.uspto.gov
17
Medical Device Patents Compound Annual Growth
Rate(1999-2003)
Source www.uspto.gov
18
Number of BioPharma Patents per million Capita
Source www.uspto.gov
19
Life Science Patents of Total Patents
Registered
Source www.uspto.gov
20
Financing Life Sciences Activities 2004
Source ILSI and Industry Reports
21
Companies Receiving Grants from the Chief
Scientist by Industry 2004
Source Israeli Money Tree Survey
22
Venture Capital Investments in Israel 1997
2005 (Mill )
Source Israeli Money Tree Survey
23
Percent of Venture Capital Investments in Medical
Device / Biotechnology
Source Israeli Money Tree Survey